EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

Targeted therapy of metastatic colorectal cancer (mCRC) with monoclonal antibody anti-epidermal growth factor receptor (EGFR) agents, such as cetuximab (CTX) or panitumumab, is the treatment strategy of choice in patients characterised by a wild-type (wt) RAS gene status. However, despite selection...

Descripción completa

Detalles Bibliográficos
Autores principales: CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315084/
https://www.ncbi.nlm.nih.gov/pubmed/25663927
http://dx.doi.org/10.3892/ol.2015.2876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315084/
https://www.ncbi.nlm.nih.gov/pubmed/25663927
http://dx.doi.org/10.3892/ol.2015.2876

Ejemplares similares